Department of Epidemiology and Health Monitoring, Robert Koch Institute, 12101 Berlin, Germany.
J Diabetes Res. 2018 Oct 14;2018:5703652. doi: 10.1155/2018/5703652. eCollection 2018.
Previous studies investigating determinants of changes in glycemic status among individuals with prediabetes mainly focused on glucose-defined prediabetes. In this study, we examined determinants of a regression to normoglycemia or a progression to diabetes among individuals with HbA1c-defined prediabetes. The study included 817 participants (18-79 years) with prediabetes (HbA1c 5.7-6.4% (39-47 mmol/mol)) at baseline. Glycemic status at follow-up was categorized as diagnosed diabetes (self-reported physician diagnosis or antidiabetic medication), undiagnosed diabetes (HbA1c ≥ 6.5% (≥48 mmol/mol)), prediabetes (as defined at baseline), and normoglycemia (HbA1c < 5.7% (<39 mmol/mol)). Determinants of glycemic changes were identified by multinomial logistic regression (OR (95% CI)), with those remaining in the prediabetic state as reference. During a mean follow-up time of 12.0 years, 33.8% of the participants reverted to normoglycemia, 7.2% progressed to undiagnosed diabetes, 12.8% progressed to diagnosed diabetes, and 46.2% remained prediabetic. Determinants of a regression to normoglycemia were female sex (male vs. female: 0.67 (0.46; 0.98)) and higher HDL cholesterol levels (1.17 (1.02; 1.35) per 10 mg/dl). Determinants of a progression to undiagnosed or diagnosed diabetes were higher values of BMI (1.10 (1.02; 1.18); 1.13 (1.06; 1.21) per kg/m), waist circumference (1.04 (1.01; 1.07); 1.06 (1.03; 1.09) per cm), alanine aminotransferase (1.06 (1.03; 1.09); 1.07 (1.03; 1.10) per U/l), and gamma-glutamyl transferase (1.02 (1.00; 1.03); 1.03 (1.01; 1.04) per U/l). Higher age (1.04 (1.02; 1.06) per year), female sex (male vs. female: 0.56 (0.33; 0.97)), and parental history of diabetes (yes vs. no: 1.82 (1.05; 3.15)) were further associated with a progression to diagnosed diabetes, whereas higher triglyceride levels (1.03 (1.01; 1.06) per 10 mg/dl) were associated with a progression to undiagnosed diabetes. In conclusion, among the investigated determinants, potentially modifiable anthropometric and metabolic markers were associated with glycemic changes in individuals with HbA1c-defined prediabetes. The findings of this study demonstrate the need for more refined case finding strategies for diabetes prevention.
先前研究个体糖尿病前期血糖变化的决定因素主要集中在葡萄糖定义的糖尿病前期。本研究旨在探讨糖化血红蛋白(HbA1c)定义的糖尿病前期患者血糖正常化或进展为糖尿病的决定因素。研究纳入了 817 名基线时患有 HbA1c 定义的糖尿病前期(5.7-6.4%(39-47mmol/mol))的参与者。随访时的血糖状态分为确诊糖尿病(自我报告的医生诊断或抗糖尿病药物)、未确诊糖尿病(HbA1c≥6.5%(≥48mmol/mol))、糖尿病前期(如基线时定义)和血糖正常(HbA1c<5.7%(<39mmol/mol))。采用多项逻辑回归(OR(95%CI))确定血糖变化的决定因素,以仍处于糖尿病前期状态为参考。在平均 12.0 年的随访期间,33.8%的参与者血糖恢复正常,7.2%进展为未确诊糖尿病,12.8%进展为确诊糖尿病,46.2%仍处于糖尿病前期。血糖正常化的决定因素为女性(男性与女性:0.67(0.46;0.98))和较高的高密度脂蛋白胆固醇水平(每 10mg/dl 增加 1.17(1.02;1.35))。进展为未确诊或确诊糖尿病的决定因素为体重指数(1.10(1.02;1.18);1.13(1.06;1.21)每公斤/平方米)、腰围(1.04(1.01;1.07);1.06(1.03;1.09)每厘米)、丙氨酸氨基转移酶(1.06(1.03;1.09);1.07(1.03;1.10)每单位)和γ-谷氨酰转移酶(1.02(1.00;1.03);1.03(1.01;1.04)每单位)更高。年龄(每年 1.04(1.02;1.06))、女性(男性与女性:0.56(0.33;0.97))和父母糖尿病史(是与否:1.82(1.05;3.15))与确诊糖尿病的进展进一步相关,而甘油三酯水平更高(每 10mg/dl 增加 1.03(1.01;1.06))与未确诊糖尿病的进展相关。总之,在所研究的决定因素中,潜在可改变的人体测量和代谢标志物与 HbA1c 定义的糖尿病前期患者的血糖变化有关。本研究结果表明,需要更精细的糖尿病预防病例发现策略。